Work

A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma

Year: 2024

Type: article

Source: Anti-Cancer Agents in Medicinal Chemistry

DOI: 10.2174/0118715206316190240527160242

Authors: Chenicheri Kizhakkeveettil Keerthana, Sreekumar U. Aiswarya, Tennyson P. Rayginia, Yadu Vijayan, Shirly James, Sadiq C. Shifana, Sankar Sundaram, D.K. Induja, Ravi S. Lankalapalli, Kuzhuvelil B. Harikumar, Ruby John Anto

Institutions: University of Kerala, Rajiv Gandhi Centre for Biotechnology, Government Medical College, National Institute for Interdisciplinary Science and Technology

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401523704

FWCI: 0.681

Cites: 56

Cited by: 3

Related to: 10